ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2026
Sex and ovarian hormone status shape baseline cardiovascular physiology in Sprague Dawley rats.
Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Sex is increasingly recognized as a critical biological variable in preclinical cardiovascular research, yet baseline physiological differences between male and female animals-and the experimental decisions that shape their interpretation-remain incompletely defined. Here, we establish a quantitative experimental framework by systematically characterizing growth trajectories, cardiac scaling, anesthetic sensitivity, estrous-cycle effects, and myocardial mechanics in male, ovary-intact female, and ovariectomized (OVX) female Sprague Dawley rats. Marked sex- and hormone-dependent differences in body growth rendered simultaneous age- and weight-matching impractical and led to distinct-and sometimes opposing-inferences regarding normalized cardiac mass depending on cohort standardization strategy. Baseline hemodynamics were comparable across sex and estrous stage, whereas ovarian hormone status modulated right ventricular structure and passive myocardial mechanics. Physiological fluctuations in estrogen were associated with estrogen-dependent changes in right ventricular mass, thickness, and compliance, whereas early ovariectomy produced persistent increases in myocardial stiffness independent of hemodynamic load. OVX females also exhibited heightened sensitivity to isoflurane during surgical procedures, particularly during early operative phases. Together, these findings demonstrate that sex, circulating estrogen, and timing of ovarian hormone loss shape baseline cardiovascular phenotypes. Rather than treating sex-related variability as experimental noise, this study provides practical guidance for experimental design, normalization, and interpretation in preclinical cardiovascular research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.